These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1685793)

  • 1. Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder.
    Ansseau M; Olié JP; von Frenckell R; Jourdain G; Stehle B; Guillet P
    Psychopharmacology (Berl); 1991; 104(4):439-43. PubMed ID: 1685793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suriclone and diazepam in the treatment of neurotic anxiety. A double-blind cross-over trial.
    Gerlach J; Christensen JK; Christensen TL; Elley J; Jensen JP; Larsen SB
    Psychopharmacology (Berl); 1987; 93(3):296-300. PubMed ID: 2893410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of suriclone, lorazepam and placebo in anxiety disorder.
    de Jonghe F; Swinkels J; Tuynman-Qua H; Jonkers F
    Pharmacopsychiatry; 1989 Nov; 22(6):266-71. PubMed ID: 2575766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study.
    Fontaine R; Beaudry P; Beauclair L; Chouinard G
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):189-97. PubMed ID: 2888159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative neurologic effects of diazepam and suriclone, a cyclopyrrolone anxiolytic.
    Shaw CA; Sellers EM; Sullivan JT; Kaplan HL
    J Clin Psychopharmacol; 1988 Jun; 8(3):189-92. PubMed ID: 2897978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    Maletzky BM
    J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.
    Jacobson AF; Goldstein BJ; Dominguez RA; Steinbook RM
    J Clin Psychiatry; 1983 Aug; 44(8):296-300. PubMed ID: 6135690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of buspirone and diazepam in generalized anxiety disorder.
    Jacobson AF; Dominguez RA; Goldstein BJ; Steinbook RM
    Pharmacotherapy; 1985; 5(5):290-6. PubMed ID: 2866493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder.
    Cutler NR; Hesselink JM; Sramek JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 May; 18(3):447-63. PubMed ID: 7915845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buspirone: multicenter efficacy study.
    Wheatley D
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a putative anxiolytic agent: ipsapirone.
    Borison RL; Albrecht JW; Diamond BI
    Psychopharmacol Bull; 1990; 26(2):207-10. PubMed ID: 1978371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R; Annable L; Chouinard G; Ogilvie RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):80-7. PubMed ID: 6132936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder.
    Hackett D; Haudiquet V; Salinas E
    Eur Psychiatry; 2003 Jun; 18(4):182-7. PubMed ID: 12814852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind study of metaclazepam versus diazepam treatment of outpatients with anxiety syndrome.
    Laakmann G; Blaschke D; Hippius H; Schewe S
    Pharmacopsychiatry; 1989 May; 22(3):120-5. PubMed ID: 2568645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
    Anhalt HS; Young R; Roginsky M
    J Clin Psychiatry; 1980 Nov; 41(11):386-92. PubMed ID: 6108319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial.
    Rickels K; Schweizer E; DeMartinis N; Mandos L; Mercer C
    J Clin Psychopharmacol; 1997 Aug; 17(4):272-7. PubMed ID: 9241006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suriclone: a new anxiolytic drug.
    Lapierre YD; Oyewumi KL
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):805-7. PubMed ID: 6141620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder.
    Feighner JP; Merideth CH; Hendrickson GA
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):103-8. PubMed ID: 6130066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo.
    Casacchia M; Bolino F; Ecari U
    Curr Med Res Opin; 1990; 12(4):215-23. PubMed ID: 1981698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.
    Llorca PM; Spadone C; Sol O; Danniau A; Bougerol T; Corruble E; Faruch M; Macher JP; Sermet E; Servant D
    J Clin Psychiatry; 2002 Nov; 63(11):1020-7. PubMed ID: 12444816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.